225 related articles for article (PubMed ID: 1847256)
1. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
[TBL] [Abstract][Full Text] [Related]
2. [Construction and identification of the replication-deficient recombinant vaccinia virus co-expressing HPV type 16 L1 and L2 proteins].
Han L; Ren J; Liang Y; Tian H; Zhi H; Luo W; Lu Z; Wei L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):256-60. PubMed ID: 12665934
[TBL] [Abstract][Full Text] [Related]
3. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.
Zhou J; Sun XY; Stenzel DJ; Frazer IH
Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586
[TBL] [Abstract][Full Text] [Related]
4. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.
Gao L; Chain B; Sinclair C; Crawford L; Zhou J; Morris J; Zhu X; Stauss H
J Gen Virol; 1994 Jan; 75 ( Pt 1)():157-64. PubMed ID: 7509369
[TBL] [Abstract][Full Text] [Related]
5. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.
Sadovnikova E; Zhu X; Collins SM; Zhou J; Vousden K; Crawford L; Beverley P; Stauss HJ
Int Immunol; 1994 Feb; 6(2):289-96. PubMed ID: 7512375
[TBL] [Abstract][Full Text] [Related]
6. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
[TBL] [Abstract][Full Text] [Related]
7. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.
Zhou J; Crawford L; McLean L; Sun XY; Stanley M; Almond N; Smith GL
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2185-90. PubMed ID: 2170578
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of the immuno-protective activity of recombinant vaccinia virus expressing HPV58 E7].
Luo LQ; Li J; Liu X; Zhang YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):43-6. PubMed ID: 12905606
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.
Boursnell ME; Rutherford E; Hickling JK; Rollinson EA; Munro AJ; Rolley N; McLean CS; Borysiewicz LK; Vousden K; Inglis SC
Vaccine; 1996 Nov; 14(16):1485-94. PubMed ID: 9014288
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.
Ohlschläger P; Osen W; Dell K; Faath S; Garcea RL; Jochmus I; Müller M; Pawlita M; Schäfer K; Sehr P; Staib C; Sutter G; Gissmann L
J Virol; 2003 Apr; 77(8):4635-45. PubMed ID: 12663770
[TBL] [Abstract][Full Text] [Related]
11. [The recombinant vaccinia viruses expressing HPV type 16 wild or mutant E7 protein elicit immunity against tumor cells in mice].
Zhi H; Han L; Ren J; Tian HW; Lao WF; Liang Y; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):222-5. PubMed ID: 11986689
[TBL] [Abstract][Full Text] [Related]
12. [Construction of recombinant vaccina virus of HPV16 and its antitumor effect].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Ruan L
Ai Zheng; 2005 Jul; 24(7):817-22. PubMed ID: 16004807
[TBL] [Abstract][Full Text] [Related]
13. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
14. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
Hagensee ME; Yaegashi N; Galloway DA
J Virol; 1993 Jan; 67(1):315-22. PubMed ID: 8380079
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.
Browne HM; Churcher MJ; Stanley MA; Smith GL; Minson AC
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1263-73. PubMed ID: 2838573
[TBL] [Abstract][Full Text] [Related]
16. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.
Meneguzzi G; Cerni C; Kieny MP; Lathe R
Virology; 1991 Mar; 181(1):62-9. PubMed ID: 1847269
[TBL] [Abstract][Full Text] [Related]
17. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
18. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes.
Coupar BE; Andrew ME; Boyle DB
Gene; 1988 Aug; 68(1):1-10. PubMed ID: 2851485
[TBL] [Abstract][Full Text] [Related]
19. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
[TBL] [Abstract][Full Text] [Related]
20. Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.
Zhang Y; Keck JG; Moss B
J Virol; 1992 Nov; 66(11):6470-9. PubMed ID: 1404599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
